Home Newsfeeds Morgan Stanley Maintains Equal-Weight on First Solar, Raises Price Target to $146

Morgan Stanley Maintains Equal-Weight on First Solar, Raises Price Target to $146

Morgan Stanley analyst Stephen Byrd maintains First Solar (NASDAQ:FSLR) with a Equal-Weight and raises the price target from $136 to $146.

byBenzinga Newsdesk

September 22, 2022

1 minute read

Morgan Stanley analyst Stephen Byrd maintains First Solar (NASDAQ:FSLR) with a Equal-Weight and raises the price target from $136 to $146.

Lexicon’s Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study

By Vandana Singh

November 15, 11:00 AM

Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) announced that full results from the RELIEF-DPN-1 trial of its investigational drug LX9211 were presented at the…

LXRX

Cramer On Carnival Stock: ‘Pay Close Attention’

By Benzinga Newsbot

June 22, 9:42 PM

On Monday, CNBC’s Jim Cramer provided insights into the upcoming week’s stock market trends, focusing on the shift…

CCL

Analyst Ratings

Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts

By Benzinga Insights

May 6, 3:00 PM

4 analysts have expressed a variety of opinions on Amneal Pharmaceuticals (NASDAQ:AMRX) over the past quarter, offering a…

AMRX

Porch Group Receives $25M With Signing of Strategic Agreement With Aon

By Benzinga Newsdesk

January 25, 5:38 PM

Porch Group, Inc. ("Porch", "Porch Group" or "the Company") (NASDAQ:PRCH), a leading vertical software company reinventing the home services and insurance industries, today announced it signed a strategic business

PRCH

Morgan Stanley Maintains Equal-Weight on First Solar, Raises Price Target to $146

Related Posts

Lexicon’s Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study

Cramer On Carnival Stock: ‘Pay Close Attention’

Assessing Amneal Pharmaceuticals: Insights From 4 Financial Analysts

Porch Group Receives $25M With Signing of Strategic Agreement With Aon